Cadila Healthcare's Q4FY16 consolidated net profit declines 11% yoy to Rs.388.70 crore : Beats Estimates

India Infoline News Service | Mumbai |

The company’s consolidated revenue stood at Rs. 2,449.10 crore, up 7.03% yoy and 0.85% qoq.

Cadila Healthcare
Cadila Healthcare, global pharmaceutical company, reported consolidated net profit of Rs.388.70 crore for the quarter ended March 31, 2016, registering growth of 10.94% yoy, but decline of 0.23% qoq. The company’s revenue stood at Rs. 2,449.10 crore, up 7.03% yoy and 0.85% qoq.

Its consolidated core operating profit of Rs. 581.40 crore for the quarter, clocked growth of 17.24% yoy and 0.47% qoq. Operating profit margin for the current quarter at 23.74% expanded by 207 bps yoy but contracted by 9 bps qoq.

For the year ended March 31, 2016, the company reported consolidated net profit of Rs. 1,522.60 crore, growing by 32.33% yoy. Its consolidated revenue for the period stood at Rs. 9,837.62 crore, registering growth of 13.71% yoy.

Cadila Healthcare Ltd's core operating profit stood at Rs. 2,382.90 crore, recording growth of 35.72% yoy. Operating margin for the current period at 24.13% expanded by 384 bps yoy.

On standalone basis,Cadila Healthcare Ltd, reported standalone net profit of Rs.338 crore for the quarter ended March 31, 2016, registering decline of 2.61% yoy and 28.01% qoq. The company’s standalone revenue stood at Rs. 1,429.10 crore, down 1.71% yoy and 18.66% qoq.

Its standalone core operating profit of Rs. 583.40 crore for the quarter, clocked growth of 4.65% yoy but decline of 19.69% qoq. Operating profit margin for the current quarter at 40.82% expanded by 248 bps yoy but contracted by 52 bps qoq.

For the year ended March 31, 2016, the company reported standalone net profit of Rs. 1,977.33 crore, growing by 55.55% yoy. Its standalone revenue for the period stood at Rs. 7,035.37 crore, registering growth of 33.13% yoy.

Cadila Healthcare Ltd's core operating profit stood at Rs. 3,039.20 crore, recording growth of 57.53% yoy. Operating margin for the current period at 42.8% expanded by 629 bps yoy.

Result Highlights: (Rs. in crore)

Reported Results IIFL Estimates Variance (%)
Consolidated Revenue 2449.1 2421 1.16
Consolidated Net Profit 388.7 365 6.49

Consolidated EPS for the quarter stood at Rs. 3.30.

Bloomberg estimated the company’s consolidated net profit at Rs. 384.19 crore.

Stock Commentary:

Cadila Healthcare Ltd is currently trading at Rs. 328.95, down by 4.5 points or 1.35% from its previous closing of Rs. 333.45 on the BSE.

The scrip opened at Rs. 335.85 and has touched a high and low of Rs. 339 and Rs. 324.5 respectively. So far 665354(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 34136.7 crore.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 454.4 on 23-Oct-2015 and a 52 week low of Rs. 295.5 on 18-Jan-2016. Last one week high and low of the scrip stood at Rs. 338.9 and Rs. 315.5 respectively.

The promoters holding in the company stood at 74.79 % while Institutions and Non-Institutions held 13.85 % and 11.36 % respectively.

The stock is currently trading below its 200 DMA.



***Note: This is a NSE Chart

 

Advertisements

  • Get your free IIFL Demat & Trading A/c now...Click here
  • Get IIFL express personal loan disbursal in just 8* hours...Know More
  • Get the most detailed result analysis on the web - Real Fast!
  • Actionable & Award-Winning Research on 500 Listed Indian Companies.